All about alliWeight-loss drug alli was launched in Ireland earlier this year and is sold without prescription inpharmacies. Consumer Choice questions the wisdom of this decision.
Earlier this year a licence was granted to
with dieting, its side effects are milder
and the package leaflet and the label will
fat. Alli should only be used by adults of
Medicines Agency’s (EMEA, see Useful
supply of a centrally authorised medicine
their customers fit these criteria. Alli costs
AT A GLANCE What is alli? What is alli?
bought in a smaller dose. It should not be
How alli works. Consumer action.
HEALTH NOVEMBER 2009 consumer choice
We decided to visit a number of pharmacies in August and September
ARE PHARMACIES FOLLOWING THE RULES?
2009 to determine whether pharmacists are sticking to the regulations
LOCATION CHECKED/ WILLING TO ASKED BMI?
A press release announcing the launch of alli in pharmacies in Ireland
in April 2009 stated the following: “Accompanied by an extensive
pharmacy training and education programme, alli is being launched in
pharmacies with full support to ensure that the pharmacy team is well
equipped to advise on correct usage and help users achieve maximum
benefit from the treatment. Alli therefore represents a real opportunity for
overweight and obese people to benefit significantly from professional
pharmacy intervention.” GSK also said at the time that it takes the need
to market alli responsibly very seriously, and is training pharmacists to
Ranelagh, Dublin 6
help them provide advice on weight loss, to ensure they recommend alli
Inchicore, Dublin 8
to suitable patients only. GSK’s head of regulatory and external affairs
Dundrum, Dublin 14
Niall O'Shea stated that "The pharmacies will check the individual is over
Dundrum, Dublin 14
18, with a BMI of 28 or over, and will ask further questions."
Drogheda, Co. Louth
Unfortunately our investigation found that this is not necessarily true in
Naas, Co. Kildare
all cases, and in eight of the 20 pharmacies we visited, a pharmacist
Naas, Co. Kildare
was found to be willing to sell alli to our researcher despite the fact that
Portlaoise , Co. Laois
the researcher has a BMI of 19.1. This is contraindicated under the
Limerick City Centre
requirement that users have a BMI of 28 or over before they are sold alli
Limerick City Centre Limerick City Centre
During the investigation we found some of the pharmacists were
Limerick City Centre
deeply concerned that somebody with a BMI of under 28 was attempting
Limerick City Centre
to purchase alli. They warned that it would be dangerous to take, and
refused to sell it. However other pharmacists did not even question the request and one even asked if it worked effectively. It is worrying
to see how lax pharmacists can be when it comes to advising customers about alli. Do our results, which show that a person with a BMI
of 19 has almost a 50/50 chance of obtaining alli, mean that if someone has a BMI closer to 28 they have an even greater chance of
obtaining the medicine? We believe there is a lot of room for improvement in this area. The responsibility has mainly been placed on
pharmacists to regulate the sale of alli and therefore there should be stiff penalties for pharmacies that do not comply with the conditions
of sale, such as checking the age of the customer and their BMI. “the European Commission’s decision to approve alli for sale over-the-counter is not in the best interests of consumers, because the easy availability of the drug generates the potential for abuse, particularly in vulnerable groups such as teenagers and people with eating disorders”
in conjunction with a low-calorie, low-fat
available in Ireland as a prescription-only
with unpleasant side effects. There are no
recent report in the Irish Times, the
even if you take alli, you still have to eat
up by GSK for its Irish customers, “When
How does alli work?
of studies have evaluated the effectiveness
additional 1lb.” The manufacturers also
user absorbs. The fat does not get broken
on its prescription-strength counterpart,
Xenical.” Alli is not suitable for those
instead. The tablets are meant to be used
consumer choice NOVEMBER 2009 HEALTH
reports for orlistat, the prescription dose
Useful contacts
of alli. The FDA releases a quarterly list of
their appearance on the list "does not
IMB Irish Medicines
relationship" with the drug. In August,
pressure checks or tests for diabetes.
approve alli for sale over-the-counter is
liver injury in patients taking orlistat. The
Mayo Clinic Side effects
because the easy availability of the drug
described were jaundice (yellowing of the
skin or whites of the eyes), weakness, and
particularly in vulnerable groups such as
with oily spotting. These side effects all
doses of prescription Xenical. The two US
highlighted the problem of alli being too
limited by keeping to a low-fat diet. Alli
patients were hospitalised, and six cases
therefore does not get rid of existing fat;
drug and have tried to fight against it. In
resulted in liver failure. "The FDA's
it just helps to stop additional fat from
analysis of these data is ongoing, and no
decided to give alli the temporary status
definite association between liver injury
and orlistat has been established at this
and K by the body, so patients using alli
moment it is not sold over the counter.
time," the agency said. It advised that
fear of suffering the side effects may scare
consult a doctor if they have symptoms of
users into avoiding fatty foods altogether.
benefits. If a person doesn’t get enough
use it or about the importance of changes
investigation into the availability of alli
available in pharmacies. The IMB said “All
pains and depression (see ‘Essential Fats’,
Consumer Choice, April 2008, p137).
see the results on page 406, opposite.
disorders and are consistent with the type
Consumer action Orlistat probe
closely monitoring experience with use of
Due to the EMEA’s decision, alli can be
alli nationally”. It said it had no reports of
Administration (FDA, see Useful contacts)
a liver-related adverse reaction. Healthcare
further need for authorisation at national
listed alli among two dozen drugs that it
level. The weight-loss aid is already being
Report by
pharmacies in many European countries.
it was continuing to evaluate liver toxicity
Sinéad Mc Mahon cc
number of internet sites. The CAI advises
choice comment
Weight-loss drugs should not be available without a prescription and the advertising of alli should
internet. The supply of prescription-only
be curbed immediately. As our investigation shows, if users are not being monitored, it is too easy
medicines via mail order is illegal.
for anybody who wants this medication to obtain it. This opens up the potential for abuse. Another
concern is that people could take more than the recommended dosage of alli, making it the same
strength as Xenical, which is a prescription-only drug. This could put the user’s life at risk or lead
to serious health problems. Slimming pills should only ever be used with support and dietary
advice because taking a pill does nothing to change the habits which may contribute to a person
and their supply is not permitted, even if
being overweight. Direct supervision by a healthcare professional would mean that patients’
they are non-prescription only products.
progress is monitored and the pills are not taken indefinitely. If you are concerned about your
weight you should talk to your doctor who can take any other underlying health issues you may
(IMB, see Useful contacts), up to 50% of
have into account. A weight loss supplement should not be used to substitute a balanced diet and
regular exercise – there is no quick-fix.
HEALTH NOVEMBER 2009 consumer choice
Editorial submitted for Volume 30 IJO but never published Has the International Journal of Obesity been a success? Alan N.Howard, Downing College, University of Cambridge, Cambridge CB2 1DQ,UK On the occasion of the publication of the 30th volume , it is appropriate to consider how and why the International Journal of Obesity(IJO ) was started and if it has lived up to the aspi
July (1) 2007 A Cluster Randomized Clinical Trial to Improve Prescribing Patterns in Ambulatory Pediatrics. A Plan for Achieving Significant Improvement in Patient Safety. Cost-Effective Enhancement of Claims Data to Improve Comparisons of Patient Safety. Health Literacy: The Cornerstone of Patient Safety. Improving Patient Safety and Communication Through Care Rounds in a